Correlation Between Iteos Therapeutics and MoonLake Immunotherapeuti

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and MoonLake Immunotherapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and MoonLake Immunotherapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and MoonLake Immunotherapeutics, you can compare the effects of market volatilities on Iteos Therapeutics and MoonLake Immunotherapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of MoonLake Immunotherapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and MoonLake Immunotherapeuti.

Diversification Opportunities for Iteos Therapeutics and MoonLake Immunotherapeuti

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Iteos and MoonLake is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and MoonLake Immunotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MoonLake Immunotherapeuti and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with MoonLake Immunotherapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MoonLake Immunotherapeuti has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and MoonLake Immunotherapeuti go up and down completely randomly.

Pair Corralation between Iteos Therapeutics and MoonLake Immunotherapeuti

Given the investment horizon of 90 days Iteos Therapeutics is expected to under-perform the MoonLake Immunotherapeuti. But the stock apears to be less risky and, when comparing its historical volatility, Iteos Therapeutics is 1.27 times less risky than MoonLake Immunotherapeuti. The stock trades about -0.14 of its potential returns per unit of risk. The MoonLake Immunotherapeutics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  4,805  in MoonLake Immunotherapeutics on August 28, 2024 and sell it today you would earn a total of  479.00  from holding MoonLake Immunotherapeutics or generate 9.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Iteos Therapeutics  vs.  MoonLake Immunotherapeutics

 Performance 
       Timeline  
Iteos Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iteos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
MoonLake Immunotherapeuti 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MoonLake Immunotherapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, MoonLake Immunotherapeuti showed solid returns over the last few months and may actually be approaching a breakup point.

Iteos Therapeutics and MoonLake Immunotherapeuti Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iteos Therapeutics and MoonLake Immunotherapeuti

The main advantage of trading using opposite Iteos Therapeutics and MoonLake Immunotherapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, MoonLake Immunotherapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MoonLake Immunotherapeuti will offset losses from the drop in MoonLake Immunotherapeuti's long position.
The idea behind Iteos Therapeutics and MoonLake Immunotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Transaction History
View history of all your transactions and understand their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals